Merck
CN
HomeWebinars3D-Printable Hydrogel-Based and Particle-Based Biomaterial Ink Platforms

3D-Printable Hydrogel-Based and Particle-Based Biomaterial Ink Platforms



WEBINAR

What Does It Cover?

3D-printing has emerged as a very promising fabrication platform for complex tissue engineering. However, a significant limitation is the availability of biomaterial inks that can be 3D-printed into highly, biologically functional materials and structures. Join us as Professor Ramille Shah and Dr. Adam Jakus of the Shah Tissue Engineering and Additive Manufacturing (TEAM) Laboratory discuss their work to expand the current 3D-printable material toolbox. They will review not only the an extensive variety of tailorable, functional, and clinically friendly biomaterials and corresponding medical constructs, but also additional materials, such as metals, alloys, graphene, and ceramics.

What Will You Learn?

Viewers will learn about:

  • Two new, distinct 3D-printable material platforms, Hydrogel Bioprinting and 3D-Painting, that  have been developed and  extended to create hundreds of distinct 3D-printable materials.
  • The unique and advantageous properties of the new materials.
  • Several new, specific, examples for the evolving area of 3D painting, including 3D-graphene, Hyperelastic "Bone", material mixtures, and new hydrogels for liver, kidney, and ovarian tissues.

View Presentation Slides

Speakers

Ramille Shah, Ph.D.

Ramille Shah, Ph.D.

Dimension Inx, LLC

Co-Founder and Chief Scientific Officer

Ramille Shah, Ph.D. is the co-founder and Chief Scientific Officer of Dimension Inx, LLC, a start-up developing transformative advanced manufacturing materials and processes for medical and non-medical spaces. Professor Ramille Shah has over 20 years experience in the biomaterials and tissue engineering fields with an expertise in developing and characterizing new biomaterial strategies for tissue and organ regeneration including the use of natural and synthetic polymer systems, self-assembling biomaterials, gene and growth factor delivery systems, and 3D-printable biomaterials that have led to over a dozen issued and pending patents, as well as high impact publications in journals such as Science, Advanced Materials, and Science Translational Medicine. She spent 9 years at Northwestern University as an Assistant Professor with a joint appointment in Materials Science and Engineering and Surgery (Transplant Division) and was recently recruited to the University of Illinois at Chicago in the Department of Bioengineering where she is currently a part time Associate Professor. As head of the Shah Tissue Engineering and Additive Manufacturing (TEAM) Lab, she has been focusing on the development, characterization, and translation of new functional 3D-printable materials that are compatible with room temperature extrusion-based 3D printing for both biomedical (e.g. complex tissue and organ engineering) and non-biomedical (e.g. energy and advanced structural) applications.

Adam Jakus, Ph.D.

Adam Jakus, Ph.D.

Dimension Inx, LLC

Co-Founder and Chief Technology

Adam Jakus, Ph.D. is the co-founder and Chief Technology of Dimension Inx, LLC, a start-up developing transformative advanced manufacturing materials and processes for medical and non-medical spaces. Adam received his BS and MS degrees in Materials Science and Engineering from Georgia Tech, where he worked on the development and testing of new energetic material systems. In 2010, he began working at Northwestern University with Dimension Inx’s other co-founder, Ramille Shah, Ph.D. While at Northwestern, Adam invented and developed an entirely new, materials-centric approach to 3D-printing and advanced manufacturing, now referred to as 3D-Painting, and hundreds of new 3D-printable materials for medical and non-medical purposes. These materials include, but are not limited to the high tissue and organ regenerative Hyperelastic Bone™, 3D-Graphene, Tissue Papers, and Fluffy-X. With approximately 10 years and many thousands of hours of bioprinting and tissue regenerative 3D-Printing experience, Adam leads the field, providing expertise to several not-for-profit bodies looking to establish guidelines, guidance, and certifications related to the emerging fields of tissue and organ fabrication. He is the author of numerous granted and pending patents, high impact medical and non-medical publications, book chapters, and editorials related to advanced manufacturing and 3D-printing of biomaterials and non-materials.

登录以继续。

如要继续阅读,请登录或创建帐户。

暂无帐户?